Elusys Therapeutics
Latest round
- Series E
Last raised
- Jan 2007
Total raised
- $43M
Investors
- 6
About Elusys Therapeutics
Elusys Therapeutics, Inc.Founded in 1998 and headquartered in Parsippany, US, Elusys Therapeutics specializes in medical countermeasures. The company has undergone strategic developments and was acquired by Heat Biologics, Inc. in December 2021, with the deal expected to close in early 2022. Elizabeth Posillico serves as CEO.Elusys Therapeutics specializes in the development and commercialization of medical countermeasures aimed at mitigating the effects of anthrax exposure. Its flagship product, ANTHIM® (obiltoxaximab), has been commercially available in the United States since 2016 and in Canada since 2020.Elusys Therapeutics has secured over USD 450 mn in procurement and development contracts, primarily through collaborations with governmental health organizations. The company is exploring new product designs and potential launches, though specific details and dates are not yet disclosed. With the anticipated closing of the acquisition by Heat Biologics, Elusys may broaden its market presence and develop additional strategic partnerships to further its growth initiatives.
Who invested in Elusys Therapeutics
6 investors across 4 rounds
See all investors in Elusys Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Elusys Therapeutics
Who invested in Elusys Therapeutics?
Elusys Therapeutics has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Elusys Therapeutics raised?
Elusys Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Elusys Therapeutics last raise money?
Elusys Therapeutics's most recent round on record is a Series E, in Jan 2007.
What does Elusys Therapeutics do?
Elusys Therapeutics is a biotechnology company.
Where is Elusys Therapeutics headquartered?
Elusys Therapeutics is headquartered in Parsippany, US.
Which VCs invest in companies like Elusys Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Elusys Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Elusys Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.